Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Accelerated Restructuring

22 Nov 2022 07:00

RNS Number : 1351H
Deepverge PLC
22 November 2022
 

DeepVerge PLC

 

("DeepVerge" or "Company")

 

Accelerated Restructuring

 

DeepVerge (AIM: DVRG) announces an organisational restructure of its environmental and life science divisions to meet the growth in demand and maximise the opportunities that lie ahead. Modern Water will focus primarily on markets in China, South Asia and EMEA. Labskin and Skin Trust Club will primarily target the North American market.

 

Over the past 24 months Modern Water has transitioned from traditional unit sales of standalone monitoring equipment to fully integrated solution sales, underpinned by data automation and AI. The result has been a number of £1m+ contracts with significant regional partners on four continents.

 

The full integration of Glanaco into Modern Water will create two sub-divisions within Modern Water - a solutions division for integrated solution sales and an equipment, assembly and logistics division run by Glanaco. Modern Water will focus primarily on markets where there is regulatory driven need for clean water.

 

Labskin and Skin Trust Club business units will transfer to Rinocloud Limited, the software and AI company acquired by DeepVerge in May 2019. Rinocloud is focused on the use of AI for analysis of aggregated microbiome data extracted from human skin and environmental water, soil, flora and fauna. Following the recently announced material wins with IARPA, NOAA and Georgia Ports, this business will primarily be focused on and in the North American market.

 

It is expected that this restructuring will also result in cost savings for the Company of up to £2.0m on an annualised basis. The incremental cash costs of implementing the reorganisation are not expected to exceed £0.2m. The Company will seek to minimise the impact of these measures on the workforce, however potential redundancies may need to be considered in some areas of the business. The anticipated result of this restructuring is the Company being in a stronger and healthier position to execute the more focused strategy.

 

Further to the notification of 14 November 2022, and as anticipated, the Company confirms it has transferred the requisite funds from the recent fundraising to Riverfort to settle all outstanding amounts under its loan facility.

Nigel Burton, CEO of DeepVerge plc commented:

"This restructuring will enable the Company to build on the unrealised value created within both business divisions in order to maximise shareholder value."

For further information, please contact:

 

Enquiries:

 

DeepVerge plc

Nigel Burton, CEO

+44 (0) 8885 234447

 

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited

(Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

 

Market Abuse Regulation (MAR) Disclosure

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPGRAGUPPPGG
Date   Source Headline
21st Oct 20217:00 amRNS2nd Generation Microtox® PD equipment shipping
15th Oct 20217:00 amRNSRelated Party Transaction
6th Oct 20217:00 amRNSDVRG engages with Media.Monks re Skin Trust Club
20th Sep 20217:00 amRNSSponsor at Reuters Conference on Climate Change
15th Sep 20217:01 amRNSIndia Centre of Excellence for Modern Water AMBC
15th Sep 20217:00 amRNSInterim Results
3rd Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Aug 20217:00 amRNSContinued progress thru' Microsaic collaboration
26th Jul 202112:25 pmRNSResult of AGM
26th Jul 20217:00 amRNSUpdate
12th Jul 20217:00 amRNSAppointment of Group Marketing Officer
7th Jul 20211:16 pmRNSExercise of Options and Total Voting Rights
30th Jun 20215:28 pmRNSNotice of AGM
30th Jun 20215:28 pmRNSFinal Results
25th Jun 20212:55 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSMicrotox Successful Phase 3 Field Trials
23rd Jun 20211:15 pmRNSResult of General Meeting
7th Jun 202112:23 pmRNS£10m Firm /Cond'l Placings & Subs - replacement
7th Jun 20219:35 amRNSFirm & Cond'l Placings & Subscription for £10m
6th May 20217:00 amRNSNew AI centre of excellence in Cork
30th Apr 20215:25 pmRNSExercise of Warrants and Total Voting Rights
30th Apr 20217:00 amRNSExercise of Warrants and Total Voting Rights
28th Apr 20217:00 amRNSDeepVerge signs MoU for JV with China Resources
26th Apr 20217:00 amRNSSkin Trust Club iOS App goes live
22nd Apr 20212:05 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:01 pmRNSPrice Monitoring Extension
21st Apr 20213:00 pmRNSExercise of Warrants and Total Voting Rights
13th Apr 20212:34 pmRNSExercise of Warrants and Total Voting Rights
13th Apr 20217:00 amRNSDirector/PDMR Shareholding
7th Apr 20213:43 pmRNSExercise of Options and Total Voting Rights
31st Mar 20217:00 amRNSUpdates on Labskin, Modern Water, Skin Trust Club
25th Mar 20213:43 pmRNSDeepVerge Investor Presentation
24th Mar 20213:37 pmRNSExercise of Warrants and Total Voting Rights
24th Mar 20212:05 pmRNSSecond Price Monitoring Extn
24th Mar 20212:00 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNS3 year Technology & Comm'l Agreem't with Microsaic
23rd Mar 20219:48 amRNSExercise of Warrants and Total Voting Rights
17th Mar 20214:22 pmRNSExercise of Warrants and Total Voting Rights
17th Mar 20217:00 amRNSMicrotox® BT Eval'n of SARS-CoV-2 from breath test
12th Mar 202111:23 amRNSAward Nomination in China
8th Mar 20214:35 pmRNSPrice Monitoring Extension
8th Mar 20217:00 amRNSChange of interests of significant shareholder
5th Mar 20213:05 pmRNSExercise of Warrants and Total Voting Rights
2nd Mar 20217:00 amRNSEcowaterOS and Microtox PD Event in China
26th Feb 202112:11 pmRNSExercise of Warrants and Total Voting Rights
17th Feb 20217:00 amRNSProd'n orders worth $5m for Modern Water Equipment
15th Feb 20217:00 amRNSProposed Framework Services Ag'ment with Microsaic
10th Feb 20217:00 amRNSDeepverge adds two virus containment laboratories
8th Feb 20217:00 amRNSDirector/PDMR Shareholding
1st Feb 20215:45 pmRNSExercise of Warrants and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.